|
⚲
|
| Keyboard |
| DeSantis Damon
✚
|
|
|---|---|
| CIK # | 0001889279 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001889279] | |
| 4 | [0001889279] | |
| SC 13D | [0001889279] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Desantis Damon | Integrated Biopharma Inc | [2026-04-17] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Integrated Biopharma Inc | |
| DeSantis Damon | |
| Celsius Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Integrated Biopharma Inc INBP
Common Stock
|
2026-03-24 | Gift | 1,356,293 | $0.00 | |
|
Integrated Biopharma Inc INBP
Common Stock
|
2026-03-24 | Gift | 7,392 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock, $0.001 par value per share
|
2026-02-27 | Grant | 2,611 | $0.00 | |
|
Integrated Biopharma Inc INBP
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 50,000 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock, $0.001 par value per share
|
2025-03-01 | Grant | 4,865 | $0.00 | |
|
Integrated Biopharma Inc INBP
Stock Option (right to buy) · derivative
|
2024-08-07 | Grant | 50,000 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock, $0.001 par value per share
|
2024-05-29 | Gift | 1,965,988 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock, $0.001 par value per share
|
2024-03-01 | Grant | 1,576 | $0.00 | |
|
Integrated Biopharma Inc INBP
Stock Option (right to buy) · derivative
|
2023-07-18 | Grant | 50,000 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock
|
2023-01-05 | Gift | 232,994 | ||
|
Celsius Holdings Inc CELH
Common Stock
|
2023-01-01 | Grant | 1,105 | ||
|
Integrated Biopharma Inc inbp
Stock Option (right to buy) · derivative
|
2022-06-20 | Grant | 50,000 | $0.00 | |
|
Celsius Holdings Inc CELH
Common Stock
|
2022-01-01 | Grant | 2,200 | ||
|
Celsius Holdings Inc CELH
Common Stock
|
2021-10-28 | Grant | 2,750 |